ACM
JNJ icon

Argyle Capital Management’s Johnson & Johnson JNJ Stock Holding History

Argyle Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.27M Sell
25,649
-255
-1% -$59.4K 2.04% 10
2025
Q4 		$5.36M Hold
25,904
– – 1.79% 12
2025
Q3 		$4.8M Hold
25,904
– – 1.66% 15
2025
Q2 		$3.96M Sell
25,904
-100
-0.4% -$15.4K 1.43% 19
2025
Q1 		$4.31M Buy
26,004
+200
+0.8% +$31.3K 1.6% 16
2024
Q4 		$3.73M Buy
25,804
+1,682
+7% +$261K 1.47% 20
2024
Q3 		$3.91M Sell
24,122
-654
-3% -$104K 1.56% 16
2024
Q2 		$3.62M Buy
24,776
+985
+4% +$146K 1.49% 21
2024
Q1 		$3.76M Buy
23,791
+600
+3% +$95.5K 1.46% 20
2023
Q4 		$3.63M Sell
23,191
-5,025
-18% -$771K 1.51% 21
2023
Q3 		$4.39M Hold
28,216
– – 1.61% 15
2023
Q2 		$4.67M Sell
28,216
-2,057
-7% -$332K 1.68% 17
2023
Q1 		$4.69M Hold
30,273
– – 1.65% 17
2022
Q4 		$5.35M Sell
30,273
-100
-0.3% -$17.3K 1.84% 13
2022
Q3 		$4.96M Hold
30,373
– – 1.93% 11
2022
Q2 		$5.39M Hold
30,373
– – 1.93% 10
2022
Q1 		$5.38M Sell
30,373
-900
-3% -$153K 1.75% 15
2021
Q4 		$5.35M Sell
31,273
-750
-2% -$123K 1.67% 15
2021
Q3 		$5.17M Sell
32,023
-175
-0.5% -$29.9K 1.71% 15
2021
Q2 		$5.3M Sell
32,198
-233
-0.7% -$38.6K 1.71% 15
2021
Q1 		$5.33M Sell
32,431
-75
-0.2% -$12.1K 1.8% 12
2020
Q4 		$5.12M Sell
32,506
-1,275
-4% -$188K 1.9% 13
2020
Q3 		$5.03M Sell
33,781
-1,237
-4% -$183K 2.06% 8
2020
Q2 		$4.92M Hold
35,018
– – 2.07% 7
2020
Q1 		$4.59M Hold
35,018
– – 2.17% 8
2019
Q4 		$5.11M Hold
35,018
– – 1.81% 11
2019
Q3 		$4.53M Buy
35,018
+50
+0.1% +$6.59K 1.71% 14
2019
Q2 		$4.87M Sell
34,968
-700
-2% -$96.9K 1.85% 11
2019
Q1 		$4.99M Hold
35,668
– – 1.92% 10
2018
Q4 		$4.6M Buy
35,668
+46
+0.1% +$6.42K 1.95% 9
2018
Q3 		$4.92M Hold
35,622
– – 1.84% 11
2018
Q2 		$4.32M Buy
35,622
+2,977
+9% +$371K 1.71% 13
2018
Q1 		$4.18M Sell
32,645
-1,100
-3% -$149K 1.66% 15
2017
Q4 		$4.71M Sell
33,745
-115
-0.3% -$16K 1.77% 14
2017
Q3 		$4.4M Sell
33,860
-980
-3% -$130K 1.73% 12
2017
Q2 		$4.61M Sell
34,840
-250
-0.7% -$31.9K 1.87% 7
2017
Q1 		$4.37M Buy
35,090
+150
+0.4% +$17.9K 1.78% 14
2016
Q4 		$4.03M Sell
34,940
-1,470
-4% -$170K 1.71% 14
2016
Q3 		$4.3M Sell
36,410
-1,860
-5% -$226K 1.86% 13
2016
Q2 		$4.64M Hold
38,270
– – 1.97% 13
2016
Q1 		$4.14M Sell
38,270
-550
-1% -$56.9K 1.88% 15
2015
Q4 		$3.99M Sell
38,820
-1,190
-3% -$120K 1.84% 15
2015
Q3 		$3.73M Sell
40,010
-200
-0.5% -$19.3K 1.82% 14
2015
Q2 		$3.92M Buy
40,210
+3,005
+8% +$301K 1.79% 17
2015
Q1 		$3.74M Hold
37,205
– – 1.67% 20
2014
Q4 		$3.89M Hold
37,205
– – 1.71% 20
2014
Q3 		$3.97M Hold
37,205
– – 1.83% 16
2014
Q2 		$3.89M Sell
37,205
-40
-0.1% -$4.04K 1.81% 17
2014
Q1 		$3.66M Sell
37,245
-500
-1% -$46.4K 1.8% 18
2013
Q4 		$3.46M Sell
37,745
-1,407
-4% -$130K 1.74% 20
2013
Q3 		$3.39M Sell
39,152
-250
-0.6% -$22.4K 1.86% 16
2013
Q2 		$3.38M Buy
+39,402
New +$3.34M 1.94% 16

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Argyle Capital Management's JNJ Position: Q1 2026 in Review

Argyle Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.98% in Q1 2026, selling an estimated $59.4K and leaving 25,649 shares worth $6.27M. The position accounts for 2.04% of the portfolio, ranked #10.

Argyle Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Argyle Capital Management held 25,649 shares of Johnson & Johnson worth $6.27M as of Q1 2026.
  • Argyle Capital Management sold 255 Johnson & Johnson shares in Q1 2026, an estimated $59.4K.
  • Johnson & Johnson made up 2.04% of Argyle Capital Management's portfolio in Q1 2026, its #10 holding.
  • Argyle Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Argyle Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.